Literature DB >> 15133410

Treatment of octogenarians: should we and how.

Robert A Phillips1, John B Kostis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133410      PMCID: PMC8109422          DOI: 10.1111/j.1076-7460.2004.3621.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  34 in total

1.  Blood pressure and five year survival in the very old.

Authors:  K Mattila; M Haavisto; S Rajala; R Heikinheimo
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

2.  Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Authors:  P K Whelton; J Y Lee; J W Kusek; J Charleston; J DeBruge; M Douglas; M Faulkner; P G Greene; C A Jones; S Kiefer; K A Kirk; B Levell; K Norris; S N Powers; T M Retta; D E Smith; H Ward
Journal:  Control Clin Trials       Date:  1996-08

3.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

4.  Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Authors:  L Hansson; T Hedner; P Lund-Johansen; S E Kjeldsen; L H Lindholm; J O Syvertsen; J Lanke; U de Faire; B Dahlöf; B E Karlberg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

5.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension.

Authors:  T J Moore; P R Conlin; J Ard; L P Svetkey
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

8.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

9.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

10.  The relationship between blood pressure and mortality in the oldest old.

Authors:  S Satish; D H Freeman; L Ray; J S Goodwin
Journal:  J Am Geriatr Soc       Date:  2001-04       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.